TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Sino Swed Biotech AB
Closing information (x1000 EUR)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
142
|
133
|
163 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
41
|
31
|
56 |
| EBITDA |
41
|
31
|
56 |
| Total assets |
79
|
69
|
91 |
| Current assets |
79
|
69
|
91 |
| Current liabilities |
0
|
5
|
15 |
| Equity capital |
68
|
55
|
68 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
86.1%
|
79.7%
|
74.7% |
| Turnover per employee |
71
|
66
|
82 |
| Profit as a percentage of turnover |
28.9%
|
23.3%
|
34.4% |
| Return on assets (ROA) |
51.9%
|
44.9%
|
61.5% |
| Current ratio |
1380.0%
|
606.7% | |
| Return on equity (ROE) |
60.3%
|
56.4%
|
82.4% |
| Change turnover |
13
|
-15
|
-10 |
| Change turnover % |
10%
|
-10%
|
-6% |
| Chg. No. of employees |
0
|
0
|
2 |
| Chg. No. of employees % |
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.